Breast diseases

PubMed Free Full Text

Breast cancer treatment: antiestrogens

Australia, New Zealand

• Royal Australian and New Zealand College of Obstetricians and Gynaecologists
  • Tamoxifen and the endometrium [2019]

Canada

• Current Oncology
  • An Overview of Long-Acting GnRH Agonists in Premenopausal Breast Cancer Patients: Survivorship Challenges and Management [2024]

Europe

• Breast
  • Patient database analysis of fulvestrant 500 mg in the treatment of metastatic breast cancer: A European perspective [2017]

High-income countries

• Cancer Reports
  • Tamoxifen use and risk of endometrial cancer in breast cancer patients: A systematic review and dose-response meta-analysis [2023]

International

• Clinical Pharmacology & Therapeutics
  • Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy [2018]

Republic of Korea

• Frontiers in Oncology
  • Effect of Tamoxifen on the Risk of Osteoporosis and Osteoporotic Fracture in Younger Breast Cancer Survivors: A Nationwide Study [2020]

South Africa

• Breast Cancer Research and Treatment
  • The impact of HIV on non-adherence for tamoxifen among women with breast cancer in South Africa [2023]

Taiwan

• Cancer Medicine
  • Gonadotropin-releasing hormone agonist treatment and ischemic heart disease among female patients with breast cancer: A cohort study [2023]

United Kingdom

• National Institute for Health and Care Excellence
  • Fulvestrant for untreated locally advanced or metastatic oestrogen-receptor positive breast cancer [2018]
  • Fulvestrant for the treatment of locally advanced or metastatic breast cancer [2011]

United States

• American College of Medical Genetics and Genomics
  • Laboratory testing of CYP2D6 alleles in relation to tamoxifen therapy [2012]

{Related topics}

• Topic
  • Breast cancer treatment